Maturitas
Volume 55 , Pages S3-S13 , 1 November 2006

Contemporary alternatives to plant estrogens for menopause

References 

  1. World menopause day [website]. Lancaster, England: International Menopause Society; 2005;[accessed December 2, 2005], available from: http://www.imsociety.org/pages/wmday.html
  2. Dennerstein L, Lehert P. Women's sexual functioning, lifestyle, mid-age, and menopause in 12 European countries. Menopause. 2004;11:778–785
  3. Singh A, Kaur S, Walia I. A historical perspective on menopause and menopausal age. Bull Indian Inst Hist Med Hyderabad. 2002;32:121–135
  4. Rizk DE, Bener A, Ezimokhai M, Hassan MY, Micallef R. The age and symptomatology of natural menopause among United Arab Emirates women. Maturitas. 1998;29:197–202
  5. Chim H, Tan BH, Ang CC, Chew EM, Chong YS, Saw SM. The prevalence of menopausal symptoms in a community in Singapore. Maturitas. 2002;41:275–282
  6. Castelo-Branco C, Palacios S, Mostajo D, Tobar C, von Helde S. Menopausal transition in Movima women, a Bolivian Native-American. Maturitas. 2005;51:380–385
  7. Avis NE, Stellato R, Crawford S, et al. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med. 2001;52:345–356
  8. Kolata G. Race to fill the void in menopause drug market. New York: The New York Times; 2002;p. 1
  9. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA. 2002;288:321–333
  10. Botanicals and botanical preparations widely used as food supplements and related products: coherent and comprehensive risk assessment and consumer information approaches [website]. Brussels: European Food Safety Authority; c 2004;[updated September 21, 2004, accessed November 14, 2005], available from: http://www.efsa.eu.int/science/sc_commitee/sc_documents/616_en.html
  11. Larsen LL, Berry JA. The regulation of dietary supplements. J Am Acad Nurse Pract. 2003;15:410–414
  12. Roemheld-Hamm B, Chasteberry . Am Fam Physician. 2005;72:821–824
  13. McKenna DJ, Jones K, Humphrey S, Hughes K. Black cohosh: efficacy, safety, and use in clinical and preclinical applications. Altern Ther Health Med. 2001;7:93–100
  14. Albertazzi P, Steel SA, Clifford E, Bottazzi M. Attitudes towards and use of dietary supplementation in a sample of postmenopausal women. Climacteric. 2002;5:374–382
  15. Mahady GB, Parrot J, Lee C, Yun GS, Dan A. Botanical dietary supplement use in peri- and postmenopausal women. Menopause. 2003;10:65–72
  16. Kass-Annese B. Alternative therapies for menopause. Clin Obstet Gynecol. 2000;43:162–183
  17. Goldstein MS, Glik D. Use of and satisfaction with homeopathy in a patient population. Altern Ther Health Med. 1998;4:60–65
  18. Schimpff SC. Complementary medicine. Curr Opin Oncol. 1997;9:327–331
  19. Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D. Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst. 2000;92:42–47
  20. Seidl MM, Stewart DE. Alternative treatments for menopausal symptoms. Qualitative study of women's experiences. Can Fam Physician. 1998;44:1271–1276
  21. Landmark Healthcare . The landmark report on public perceptions of alternative care. Sacramento, CA: Landmark Healthcare; 1997;
  22. Geller SE, Studee L, Chandra G, Knowledge . Attitudes and behaviors of health care providers for botanical and dietary supplement use for menopausal health. Menopause. 2005;12:49–55
  23. Kligler B. Black cohosh. Am Fam Physician. 2003;68:114–116
  24. In:  Upton R editors. Black cohosh rhizome [monograph on the internet]. Santa Cruz, CA: American Herbal Pharmacopoeia; 2002;[accessed 2006 July 17]. Available from: http://www.herbal-ahp.org/documents/mono_contents/black_cohosh.pdf
  25. Dog TL, Powell KL, Weisman SM. Critical evaluation of the safety of Cimicifuga racemosa in menopause symptom relief. Menopause. 2003;10:299–313
  26. Einer-Jensen N, Zhao J, Andersen KP, Kristoffersen K. Cimicifuga and Melbrosia lack oestrogenic effects in mice and rats. Maturitas. 1996;25:149–153
  27. Freudenstein J, Dasenbrock C, Nisslein T. Lack of promotion of estrogen-dependent mammary gland tumors in vivo by an isopropanolic Cimicifuga racemosa extract. Cancer Res. 2002;62:3448–3452
  28. Seidlova-Wuttke D, Jarry H, Becker T, Christoffel V, Wuttke W. Pharmacology of Cimicifuga racemosa extract BNO 1055 in rats: bone, fat and uterus. Maturitas. 2003;44(Suppl. 1):S39–S50
  29. Liu ZP, Yu B, Huo JS, Lu CQ, Chen JS. Estrogenic effects of Cimicifuga racemosa (black cohosh) in mice and on estrogen receptors in MCF-7 cells. J Med Food. 2001;4:171–178
  30. Burdette JE, Liu J, Chen SN, et al. Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J Agric Food Chem. 2003;51:5661–5670
  31. Mahady GB. Is black cohosh estrogenic?. Nutr Rev. 2003;61:183–186
  32. Black cohosh. In:  Blumenthal M editors. The ABC clinical guide to herbs. Austin, TX: American Botanical Council; 2002;p. 13–22
  33. Zava DT, Dollbaum CM, Blen M. Estrogen and progestin bioactivity of foods, herbs, and spices. Proc Soc Exp Biol Med. 1998;217:369–378
  34. Liu J, Burdette JE, Xu H, et al. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem. 2001;49:2472–2479
  35. Zierau O, Bodinet C, Kolba S, Wulf M, Vollmer G. Antiestrogenic activities of Cimicifuga racemosa extracts. J Steroid Biochem Mol Biol. 2002;80:125–130
  36. Bodinet C, Freudenstein J. Influence of Cimicifuga racemosa on the proliferation of estrogen receptor-positive human breast cancer cells. Breast Cancer Res Treat. 2002;76:1–10
  37. Osmers R, Friede M, Liske E, Schnitker J, Freudenstein J, Henneicke-von Zepelin HH. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol. 2005;105:1074–1083
  38. Frei-Kleiner S, Schaffner W, Rahlfs VW, Bodmer C, Birkhauser M. Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial. Maturitas. 2005;51:397–404
  39. Wuttke W, Seidlova-Wuttke D, Gorkow C. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas. 2003;44(Suppl. 1):S67–S77
  40. Wuttke W, Raus K, Gorkow C. Efficacy and tolerability of the black cohosh (Actea racemosa) ethanolic extract BNO 1055 on climacteric complaints: a double-blind, placebo- and conjugated estrogens-controlled study. Maturitas. 2006;55(Supp. 1):83–91
  41. Duker EM, Kopanski L, Jarry H, Wuttke W. Effects of extracts from Cimicifuga racemosa on gonadotropin release in menopausal women and ovariectomized rats. Planta Med. 1991;57:420–424
  42. Nappi RE, Malavasi B, Brundu B, Facchinetti F. Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol. Gynecol Endocrinol. 2005;20:30–35
  43. Liske E, Hanggi W, Henneicke-von Zepelin HH, Boblitz N, Wustenberg P, Rahlfs VW. Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosae rhizoma): a 6-month clinical study demonstrates no systemic estrogenic effect. J Womens Health Gend Based Med. 2002;11:163–174
  44. Lehmann-Willenbrock E, Riedel HH. Clinical and endocrinologic studies of the treatment of ovarian insufficiency manifestations following hysterectomy with intact adnexa [German]. Zentralbl Gynakol. 1988;110:611–618
  45. Raus K, Brucker C, Gorkow C, Wuttke W. First time proof of endometrial safety of the special Black cohosh extract (Actea racemosa or Cimicifuga racemosa extract) CR BNO 1055. Menopause, 2006 [Epub ahead of print].
  46. Vermes G, Banhidy F, Acs N. The effects of remifemin on subjective symptoms of menopause. Adv Ther. 2005;22:148–154
  47. Pockaj BA, Loprinzi CL, Sloan JA, et al. Pilot evaluation of black cohosh for the treatment of hot flashes in women. Cancer Invest. 2004;22:515–521
  48. Hernandez Munoz G, Pluchino S. Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer. Maturitas. 2003;44(Suppl. 1):S59–S65
  49. Jacobson JS, Troxel AB, Evans J, et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol. 2001;19:2739–2745
  50. Pepping J. Black cohosh, Cimicifuga racemosa. Am J Health Syst Pharm. 1999;56:1400–1402
  51. Lontos S, Jones RM, Angus PW, Gow PJ. Acute liver failure associated with the use of herbal preparations containing black cohosh. Med J Aust. 2003;179:390–391
  52. Whiting PW, Clouston A, Kerlin P. Black cohosh and other herbal remedies associated with acute hepatitis. Med J Aust. 2002;177:440–443
  53. Cohen SM, O’Connor AM, Hart J, Merel NH, Te HS. Autoimmune hepatitis associated with the use of black cohosh: a case study. Menopause. 2004;11:575–577
  54. NIH . In: Workshop on the safety of black cohosh in clinical studies. National Center for Complementary and Alternative Medicine; NIH Office of Dietary Supplements: Washington, DC. 2004;
  55. Thomsen M, Schmidt M. Hepatotoxicity from Cimicifuga racemosa? Recent Australian case report not sufficiently substantiated. J Altern Complement Med. 2003;9:337–340
  56. Thomsen M, Vitetta L, Sali A, Schmidt M. Acute liver failure associated with the use of herbal preparations containing black cohosh. Med J Aust. 2004;180:598–599[author reply 99–600]
  57. Davis VL, Jayo MJ, Hardy ML, et al. Effects of black cohosh on mammary tumor development and progression in MMTV-neu transgenic mice. Am Assoc Cancer Res Proc. 2003;44:R910
  58. Kupfersztain C, Rotem C, Fagot R, Kaplan B. The immediate effect of natural plant extract. Angelica sinensis and Matricaria chamomilla (Climex) for the treatment of hot flushes during menopause. A preliminary report. Clin Exp Obstet Gynecol. 2003;30:203–206
  59. Hirata JD, Swiersz LM, Zell B, Small R, Ettinger B. Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertil Steril. 1997;68:981–986
  60. Lucks BC, Sorensen J, Veal L. Vitex agnus-castus essential oil and menopausal balance: a self-care survey. Complement Ther Nurs Midwifery. 2002;8:148–154
  61. Komesaroff PA, Black CV, Cable V, Sudhir K. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women. Climacteric. 2001;4:144–150
  62. Chenoy R, Hussain S, Tayob Y, O’Brien PM, Moss MY, Morse PF. Effect of oral gamolenic acid from evening primrose oil on menopausal flushing. BMJ. 1994;308:501–503
  63. Elsabagh S, Hartley DE, File SE. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba. J Psychopharmacol. 2005;19:173–181
  64. Hartley DE, Heinze L, Elsabagh S, File SE. Effects on cognition and mood in postmenopausal women of 1-week treatment with Ginkgo biloba. Pharmacol Biochem Behav. 2003;75:711–720
  65. Hartley DE, Elsabagh S, File SE. Gincosan (a combination of Ginkgo biloba and Panax ginseng): the effects on mood and cognition of 6 and 12 weeks’ treatment in post-menopausal women. Nutr Neurosci. 2004;7:325–333
  66. Tode T, Kikuchi Y, Hirata J, Kita T, Nakata H, Nagata I. Effect of Korean red ginseng on psychological functions in patients with severe climacteric syndromes. Int J Gynaecol Obstet. 1999;67:169–174
  67. Wiklund IK, Mattsson LA, Lindgren R, Limoni C. Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. Swedish Alternative Medicine Group. Int J Clin Pharmacol Res. 1999;19:89–99
  68. Warnecke G. Psychosomatic dysfunctions in the female climacteric. Clinical effectiveness and tolerance of Kava Extract WS 1490. Fortschr Med. 1991;109:119–122
  69. Grube B, Walper A, Wheatley D. St. John's wort extract: efficacy for menopausal symptoms of psychological origin. Adv Ther. 1999;16:177–186
  70. de Klerk GJ, Nieuwenhuis MG, Beutler JJ. Hypokalaemia and hypertension associated with use of liquorice flavoured chewing gum. BMJ. 1997;314:731–732
  71. Radix angelicae sinensis. WHO monographs on selected medicinal plants. Geneva, Switzerland: WHO; 2001;
  72. Blumenthal M. Herbal medicine: expanded Commision E monographs. Newton, MA: Integrative Medicine Communications; 2003;
  73. Brown D. The use of Vitex agnus castus for hyperprolactinemia. Q Rev Nat Med. 1997, Spring;19–21
  74. McMillan TL, Mark S. Complementary and alternative medicine and physical activity for menopausal symptoms. JAMWA. 2004;59:270–277
  75. Kleijnen J, Knipschild P. Ginkgo biloba. Lancet. 1992;340:1136–1139
  76. Rudofsky G. Effect of Ginkgo biloba extract in arterial occlusive disease. Randomized placebo controlled crossover study [German]. Fortschr Med. 1987;105:397–400
  77. Bauer U. 6-Month double-blind randomised clinical trial of Ginkgo biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency. Arzneimittelforschung. 1984;34:716–720
  78. Birks J, Grimley EV, Van Dongen M. Ginkgo biloba for cognitive impairment and dementia. Cochrane database syst rev. 2002;[CD003120]
  79. Fugh-Berman A. Herb–drug interactions. Lancet. 2000;355:134–138
  80. Amato P, Christophe S, Mellon PL. Estrogenic activity of herbs commonly used as remedies for menopausal symptoms. Menopause. 2002;9:145–150
  81. In:  Blumenthal M editors. The ABC clinical guide to herbs. Austin, TX: American Botanical Council; 2003;
  82. Motherwort [website]. Science Views.com; c2003-04 [accessed December 01, 2005]. Available from: http://scienceviews.com/plants/motherwort.html.
  83. Balderer G, Borbely AA. Effect of valerian on human sleep. Psychopharmacology (Berl). 1985;87:406–409
  84. Leathwood PD, Chauffard F. Aqueous extract of valerian reduces latency to fall asleep in man. Planta Med. 1985;144–148
  85. Leathwood PD, Chauffard F, Heck E, Munoz-Box R. Aqueous extract of valerian root (Valeriana officinalis L.) improves sleep quality in man. Pharmacol Biochem Behav. 1982;17:65–71
  86. Valeriana officinalis. Alternative medicine review, vol. 9. 2004;p. 438–40
  87. Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D. St John's wort for depression-an overview and meta-analysis of randomised clinical trials. BMJ. 1996;313:253–258
  88. Linde K, Berner M, Egger M, Mulrow C. St John's wort for depression: meta-analysis of randomised controlled trials. Br J Psychiatry. 2005;186:99–107
  89. Liske E. Therapeutic efficacy and safety of Cimicifuga racemosa for gynecologic disorders. Adv Ther. 1998;15:45–53
  90. Zhou S, Chan E, Pan SQ, Huang M, Lee EJ. Pharmacokinetic interactions of drugs with St John's wort. J Psychopharmacol. 2004;18:262–276

PII: S0378-5122(06)00234-9

doi: 10.1016/j.maturitas.2006.06.012

Maturitas
Volume 55 , Pages S3-S13 , 1 November 2006

Article Tools